Appili Therapeutics presents update on ATI-1701 biodefense vaccine candidate
PremiumThe FlyAppili Therapeutics presents update on ATI-1701 biodefense vaccine candidate
24d ago
Appili Therapeutics Corrects Shareholder Payout Terms
Premium
Company Announcements
Appili Therapeutics Corrects Shareholder Payout Terms
1M ago
Appili Therapeutics Nears Acquisition by Aditxt Inc.
Premium
Company Announcements
Appili Therapeutics Nears Acquisition by Aditxt Inc.
1M ago
Appili Therapeutics Modifies Acquisition Timelines
PremiumCompany AnnouncementsAppili Therapeutics Modifies Acquisition Timelines
4M ago
Appili Therapeutics Adjusts Agreement and Loan
Premium
Company Announcements
Appili Therapeutics Adjusts Agreement and Loan
4M ago
Appili Therapeutics Advances with FDA Approvals and Funding
Premium
Company Announcements
Appili Therapeutics Advances with FDA Approvals and Funding
5M ago
Appili Therapeutics signs definitive agreement to be acquired by Aditxt
PremiumThe FlyAppili Therapeutics signs definitive agreement to be acquired by Aditxt
7M ago
Appili Therapeutics announces publication of manuscript on tularemia outbreaks
Premium
The Fly
Appili Therapeutics announces publication of manuscript on tularemia outbreaks
8M ago
Appili Therapeutics Advances Tularemia Vaccine
Premium
Company Announcements
Appili Therapeutics Advances Tularemia Vaccine
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100